采纳 发表于 2025-3-23 13:10:19
http://reply.papertrans.cn/19/1883/188258/188258_11.png鞭子 发表于 2025-3-23 15:21:42
Wrapping Drug Combinations for Therapeutic Editing of Side Effects: Systems Biology Meets Wrapping om the highly diverse cellular contexts wherein a protein may constitute a desirable or undesirable target. While dehydron wrapping enables the control of specificity, it may not be able to exclude every single toxicity-related target, especially if the latter shares with the therapeutically relevanconflate 发表于 2025-3-23 18:47:08
http://reply.papertrans.cn/19/1883/188258/188258_13.pngDEI 发表于 2025-3-24 02:02:30
http://reply.papertrans.cn/19/1883/188258/188258_14.png说明 发表于 2025-3-24 03:29:52
High-Level Quantum Chemistry Empowers the Wrapping Technology for Drug Design,her empower the paradigmatic concept of “dehydron-wrapping drug.” This type of analysis provides the required guidance for the incorporation of halogens as wrapping groups in the drug chemical scaffold. The chapter explores the possibility that the group that wraps exogenously a dehydron upon drug bcathartic 发表于 2025-3-24 09:06:50
Textbook 2015peutic drugs and to allow substantive advances in targeted molecular medicine. This book will be of interest to scientists, students and practitioners in the fields of chemistry, biophysics and biomedical engineering..不成比例 发表于 2025-3-24 13:40:39
http://reply.papertrans.cn/19/1883/188258/188258_17.pngMadrigal 发表于 2025-3-24 16:40:13
Textbook 2015ully understood at the molecular level without considering interfacial behavior..The author presents conceptual advances in molecular biophysics that herald the advent of a new discipline, .epistructural biology., centered on the interactions of water and bio molecular structures across the interfacAGATE 发表于 2025-3-24 19:06:14
http://reply.papertrans.cn/19/1883/188258/188258_19.png丰富 发表于 2025-3-25 00:47:52
Dennis S. Bernstein,David C. Hylandse and natural killer cell cytotoxicity compromised by the original drug treatment. The redesign strategy enables us to create synergies that may empower drug-based anticancer therapy, aligning the immune response with the molecularly targeted treatment while retaining the anticancer efficacy of the parental compound.